Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status

Rolof G.P. Gijtenbeek*, Kim de Jong, Ben J.W. Venmans, Femke H.M. van Vollenhoven, Anneke Ten Brinke, Anthonie J. Van der Wekken, Wouter H. van Geffen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To identify the best first-line therapy for advanced lung cancer in patients with performance status 2 without a targetable mutation or with an unknown mutation status.

Original languageEnglish
Article numberCD013382
Number of pages14
JournalCochrane Database of Systematic Reviews
Volume2019
Issue number8
DOIs
Publication statusPublished - 12-Aug-2019

Cite this